Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

PubMed Links for Books (Select 2407886)

1.

Cognitive improvement by activation of alpha7 nicotinic acetylcholine receptors: from animal models to human pathophysiology.

Thomsen MS, Hansen HH, Timmerman DB, Mikkelsen JD.

Curr Pharm Des. 2010 Jan;16(3):323-43. Review.

PMID:
20109142
2.

Neuronal nicotinic acetylcholine receptor-cholesterol crosstalk in Alzheimer's disease.

Barrantes FJ, Borroni V, Vallés S.

FEBS Lett. 2010 May 3;584(9):1856-63. doi: 10.1016/j.febslet.2009.11.036. Epub 2009 Nov 13. Review.

3.

Targeting alpha7 nicotinic acetylcholine receptors in the treatment of schizophrenia.

Hajós M, Rogers BN.

Curr Pharm Des. 2010;16(5):538-54. Review.

PMID:
19909231
4.

Molecular imaging of alpha7 nicotinic acetylcholine receptors: design and evaluation of the potent radioligand [18F]NS10743.

Deuther-Conrad W, Fischer S, Hiller A, Nielsen EØ, Timmermann DB, Steinbach J, Sabri O, Peters D, Brust P.

Eur J Nucl Med Mol Imaging. 2009 May;36(5):791-800. doi: 10.1007/s00259-008-1031-7. Epub 2009 Jan 10.

PMID:
19137292
5.

[11C]CHIBA-1001 as a novel PET ligand for alpha7 nicotinic receptors in the brain: a PET study in conscious monkeys.

Hashimoto K, Nishiyama S, Ohba H, Matsuo M, Kobashi T, Takahagi M, Iyo M, Kitashoji T, Tsukada H.

PLoS One. 2008 Sep 18;3(9):e3231. doi: 10.1371/journal.pone.0003231.

6.

SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (1) binding and functional profile.

Biton B, Bergis OE, Galli F, Nedelec A, Lochead AW, Jegham S, Godet D, Lanneau C, Santamaria R, Chesney F, Léonardon J, Granger P, Debono MW, Bohme GA, Sgard F, Besnard F, Graham D, Coste A, Oblin A, Curet O, Vigé X, Voltz C, Rouquier L, Souilhac J, Santucci V, Gueudet C, Françon D, Steinberg R, Griebel G, Oury-Donat F, George P, Avenet P, Scatton B.

Neuropsychopharmacology. 2007 Jan;32(1):1-16. Epub 2006 Oct 4.

7.

Brain nicotinic acetylcholine receptors: native subtypes and their relevance.

Gotti C, Zoli M, Clementi F.

Trends Pharmacol Sci. 2006 Sep;27(9):482-91. Epub 2006 Jul 31. Review.

PMID:
16876883
8.

Brain neuronal nicotinic receptors as new targets for drug discovery.

Gotti C, Riganti L, Vailati S, Clementi F.

Curr Pharm Des. 2006;12(4):407-28. Review.

PMID:
16472136
9.

The nicotinic acetylcholine receptor subtypes and their function in the hippocampus and cerebral cortex.

Alkondon M, Albuquerque EX.

Prog Brain Res. 2004;145:109-20. Review.

PMID:
14650910
10.

Nicotinic acetylcholine receptors: from structure to brain function.

Hogg RC, Raggenbass M, Bertrand D.

Rev Physiol Biochem Pharmacol. 2003;147:1-46. Epub 2003 Mar 20. Review.

PMID:
12783266
11.

Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications.

Nordberg A.

Biol Psychiatry. 2001 Feb 1;49(3):200-10. Review.

PMID:
11230871
12.

Role of alpha7 nicotinic receptors in nicotine dependence and implications for psychiatric illness.

Nomikos GG, Schilström B, Hildebrand BE, Panagis G, Grenhoff J, Svensson TH.

Behav Brain Res. 2000 Aug;113(1-2):97-103. Review.

PMID:
10942036
13.

A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: in vitro pharmacological properties of a novel, high affinity alpha 4 beta 2 nicotinic acetylcholine receptor ligand.

Sullivan JP, Donnelly-Roberts D, Briggs CA, Anderson DJ, Gopalakrishnan M, Piattoni-Kaplan M, Campbell JE, McKenna DG, Molinari E, Hettinger AM, Garvey DS, Wasicak JT, Holladay MW, Williams M, Arneric SP.

Neuropharmacology. 1996 Jun;35(6):725-34.

PMID:
8887981
14.

Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors.

Abreo MA, Lin NH, Garvey DS, Gunn DE, Hettinger AM, Wasicak JT, Pavlik PA, Martin YC, Donnelly-roberts DL, Anderson DJ, Sullivan JP, Williams M, Arneric SP, Holladay MW.

J Med Chem. 1996 Feb 16;39(4):817-25.

PMID:
8632405
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk